Affordable Access

deepdyve-link
Publisher Website

Management of portal hypertension and ascites in polycystic liver disease.

Authors
  • Bernts, Lucas H P1
  • Drenth, Joost P H1
  • Tjwa, Eric T T L1
  • 1 Department of Gastroenterology and Hepatology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands. , (Netherlands)
Type
Published Article
Journal
Liver international : official journal of the International Association for the Study of the Liver
Publication Date
Nov 01, 2019
Volume
39
Issue
11
Pages
2024–2033
Identifiers
DOI: 10.1111/liv.14245
PMID: 31505092
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Patients suffering from polycystic liver disease may develop Hepatic Venous Outflow Obstruction, Portal Vein Obstruction and/or Inferior Caval Vein Syndrome because of cystic mass effect. This can cause portal hypertension, leading to ascites, variceal haemorrhage or splenomegaly. For this review, we evaluate the evidence to provide clinical guidance for physicians faced with this complication. Diagnosis is made with imaging such as ultrasound, computed tomography or magnetic resonance imaging. Therapy includes conventional therapy with diuretics and paracentesis, and medical therapy using somatostatin analogues. Based on disease phenotype various (non-)surgical liver-volume reducing therapies, hepatic or portal venous stenting, transjugular intrahepatic portosystemic shunts and liver transplantation may be considered. Because of complicated anatomy, use of high-risk interventions and lack of empirical evidence, patients should be treated in expert centres. © 2019 The Authors. Liver International publised by John Wiley & Sons Ltd.

Report this publication

Statistics

Seen <100 times